明年1月泰國推動漫平台頻道 羚邦(02230.HK):目標每年收入及盈利增長達雙位數
羚邦集團(02230.HK)主席兼行政總裁趙小燕表示,自今年1月起,新播放的動漫達16至17套,目前對外授權費達雙位數增長,目標每年收入及盈利均可達致雙位數增長,冀未來能平衡媒體內容發行業務及品牌授權業務的佔比。
趙小燕指出,公司未來會繼續拓展旗下動漫平台頻道Ani-One,並於明年1月在泰國推出,預計未來一年內將拓展至越南、印尼及菲律賓。
至於集團在港澳市場獨家發行的日本動畫電影《THE FIRST SLAM DUNK》將於明年1月上映,她透露,投入今次電影的廣告開支較《劇場版咒術迴戰0》大,預計有關票房收入將會達八位數字。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.